Annals of Surgical Oncology

, Volume 24, Issue 10, pp 2869–2875 | Cite as

Breast Cancer Disparities: Socioeconomic Factors versus Biology

  • Lisa A. Newman
Breast Oncology


Disparities in poverty and health care access barriers have a negative impact on the health and wellness of population subsets that bear a disproportionate share of these socioeconomic disadvantages, such as African Americans and Hispanic/Latina Americans. The more advanced stage distribution of breast cancer in these two population subsets is likely related to imbalance in distribution of socioeconomic resources in the United States. However, differences in the breast cancer burden of population subsets defined by racial/ethnic identity are also influenced by race/ethnicity-associated variation in tumor biology and hereditary susceptibility. Compared with white Americans, African-American women have higher population-based breast cancer mortality rates, which are at least partly explained by an increased risk for the biologically aggressive triple-negative phenotype. International studies correlate West African ancestry with predisposition for triple-negative breast cancer. In contrast, Hispanic/Latina Americans have lower population-based incidence and mortality rates for breast cancer despite their increased rates of socioeconomic challenges. Genetic studies suggest that extent of Native American ancestry among Hispanic/Latina women may reduce breast cancer risk. Eradication of disparate access to breast cancer early detection and treatment strategies is a public health imperative, but research to elucidate the genetics of breast cancer related to racial/ethnic identity is equally important as we strive to comprehensively define this complex disease.



This work was partly supported by a Susan G. Komen Scholars Leadership Grant HFHS F11047 (LAN).


  1. 1.
  2. 2.
    Diabetes disparities among racial and ethnic minorities, AHRQ Pub. No. 02-P007 November 2001. Accessed 30 April 2017.
  3. 3.
    Health, United States, 2015: With special feature on racial and ethnic disparities. National Center for Health Statistics. Hyattsville, MD, 2016. Accessed 30 April 2017.
  4. 4.
    Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93.CrossRefPubMedGoogle Scholar
  5. 5.
    National Center for Health Statistics Data Brief No. 244, April 2016; Changes in Life Expectancy by Race and Hispanic Origin in the United States, 2013–2014. Accessed 30 April 2017.
  6. 6.
    Macartney S, Bishaw A, Fontenot K. Poverty rates for selected detailed race and Hispanic groups by state and place: 2007–2011; American Community Survey Briefs. In: U.S. Department of Commerce EaSA, ed. American Community Series Brief/1117: U.S. Census Bureau,; 2013.Google Scholar
  7. 7.
    DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31–42.CrossRefPubMedGoogle Scholar
  8. 8.
    Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006;24(9):1342–49.CrossRefPubMedGoogle Scholar
  9. 9.
    Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101(14):984–92.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, 1975–2011, Featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107(6):djv048.Google Scholar
  11. 11.
    Newman LA, Kaljee LM. Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg. 2017;152(5):485–93.CrossRefPubMedGoogle Scholar
  12. 12.
    Fejerman L, Ahmadiyeh N, Hu D, et al. Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. Nature Comm. 2014;5:5260.CrossRefGoogle Scholar
  13. 13.
    Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73.CrossRefPubMedGoogle Scholar
  14. 14.
    McKernan S, Ratcliffe C, Steuerle E, Zhang S. Impact of the great recession and beyond: disparities in wealth building by generation and race. Accessed 30 April 2017.
  15. 15.
    Breast cancer facts & figures 2015–2016. Atlanta: American Cancer Society, Inc. 2015.Google Scholar
  16. 16.
    Chen L, Li CI. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1666–72.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.CrossRefPubMedGoogle Scholar
  18. 18.
    Rizzo M, Lund MJ, Mosunjac M, et al. Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer. 2009;115(13):3009–15.CrossRefPubMedGoogle Scholar
  19. 19.
    Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998–2005). J Natl Cancer Inst. 2008;100(7):462–74.CrossRefPubMedGoogle Scholar
  20. 20.
    Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. JAMA Surg. 2014;149(8):788–96.CrossRefPubMedGoogle Scholar
  21. 21.
    Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol. 2005;23(27):6639–46.CrossRefPubMedGoogle Scholar
  22. 22.
    Magai C, Consedine NS, Adjei BA, Hershman D, Neugut A. Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: implications for education and intervention. Health Educ Behav. 2008;35(6):835–54.CrossRefPubMedGoogle Scholar
  23. 23.
    Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007;19(1):31–36.CrossRefPubMedGoogle Scholar
  24. 24.
    Reyes SA, King TA, Fei K, Franco R, Bickell NA. Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer. Ann Surg Oncol. 2016;23(5):1537–42.CrossRefPubMedGoogle Scholar
  25. 25.
    Connors SK, Goodman MS, Myckatyn T, Margenthaler J, Gehlert S. Breast reconstruction after mastectomy at a comprehensive cancer center. Springerplus. 2016;5(1):955.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Sisco M, Du H, Warner JP, Howard MA, Winchester DP, Yao K. Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base. J Am Coll Surg. 2012;215(5):658–66, discussion 666.CrossRefPubMedGoogle Scholar
  27. 27.
    Tseng JF, Kronowitz SJ, Sun CC, et al. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer. 2004;101(7):1514–23.CrossRefPubMedGoogle Scholar
  28. 28.
    Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14(12):3328–34.CrossRefPubMedGoogle Scholar
  29. 29.
    McCaskill-Stevens W, McKinney MM, Whitman CG, Minasian LM. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience. J Clin Oncol. 2005;23(22):5247–54.CrossRefPubMedGoogle Scholar
  30. 30.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.CrossRefPubMedGoogle Scholar
  31. 31.
    Hunt BR. Breast cancer prevalence and mortality among Hispanic subgroups in the United States, 2009-2013. J Cancer Epidemiol. 2016;2016:8784040.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Lynce F, Graves KD, Jandorf L, et al. Genomic disparities in breast cancer among Latinas. Cancer Control J Moffitt Cancer Center. 2016;23(4):359–72.CrossRefGoogle Scholar
  33. 33.
    Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999–2004. Breast J. 2009;15(6):593–602.CrossRefPubMedGoogle Scholar
  34. 34.
    Hines LM, Risendal B, Byers T, Mengshol S, Lowery J, Singh M. Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. J Women’s Health. 2011;20(10):1543–50.CrossRefGoogle Scholar
  35. 35.
    Carvalho FM, Bacchi LM, Pincerato KM, Van de Rijn M, Bacchi CE. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil. BMC Women’s Health. 2014;14:102.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Fejerman L, Chen GK, Eng C, et al. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas. Hum Mol Genet. 2012;21(8):1907–17.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Hines LM, Sedjo RL, Byers T, et al. The Interaction Between Genetic Ancestry and Breast Cancer Risk Factors among Hispanic women: The Breast Cancer Health Disparities Study. Cancer Epidemiol Biomarkers Prev. 2016.Google Scholar
  38. 38.
    O’Malley C, Shema S, White E, Glaser S. Incidence of male breast cancer in california, 1988-2000: racial/ethnic variation in 1759 men. Breast Cancer Res Treat. 2005;93(2):145–50.CrossRefPubMedGoogle Scholar
  39. 39.
    Surveillance, Epidemiology and End Results Fast Stats. Accessed 30 April 2017.
  40. 40.
    Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMedGoogle Scholar
  41. 41.
    Hershman D, Weinberg M, Rosner Z, et al. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst. 2003;95(20):1545–48.CrossRefPubMedGoogle Scholar
  42. 42.
    Newman LA, Reis-Filho JS, Morrow M, Carey LA, King TA. The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer. Ann Surg Oncol. 2015;22(3):874–82.CrossRefPubMedGoogle Scholar
  43. 43.
    Copson E, Maishman T, Gerty S, et al. Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. Br J Cancer. 2014;110(1):230–41.CrossRefPubMedGoogle Scholar
  44. 44.
    Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL. Early onset of breast cancer in a group of British black women. Br J Cancer. 2008;98(2):277–81.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Rapiti E, Pinaud K, Chappuis PO, et al. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study. Cancer Med. 2017;6(3):526–36.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Karami F, Mehdipour P. A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. BioMed Res Int. 2013;2013:928562.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Pal T, Permuth-Wey J, Holtje T, Sutphen R. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2004;13(11 Pt 1):1794–99.PubMedGoogle Scholar
  48. 48.
    Akbari MR, Donenberg T, Lunn J, et al. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. Clin Genet. 2014;85(1):64–67.CrossRefPubMedGoogle Scholar
  49. 49.
    Palmer JR, Ruiz-Narvaez EA, Rotimi CN, et al. Genetic susceptibility loci for subtypes of breast cancer in an African American population. Cancer Epidemiol Biomarkers Prev. 2013;22(1):127–34.CrossRefPubMedGoogle Scholar
  50. 50.
    Haddad SA, Ruiz-Narvaez EA, Haiman CA, et al. (2016) An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium. Carcinogenesis 37(9):870–77.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Breast Cancer Genetics Study in African Ancestry Populations. Accessed 12 Sept 2016.
  52. 52.
    Newman LA, Kaljee LM (2017) Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg 152(5):485–93.CrossRefPubMedGoogle Scholar
  53. 53.
    Jiagge E, Jibril AS, Chitale D, et al. (2016) Comparative analysis of breast cancer phenotypes in African American, white American, and West versus East African patients: correlation between African ancestry and triple-negative breast cancer. Ann Surg Oncol. 23(12):3843–49.CrossRefPubMedGoogle Scholar
  54. 54.
    Jemal A, Fedewa SA. Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than U.S.-born black women? Breast Cancer Res Treat. 2012;135(3):867–73.CrossRefPubMedGoogle Scholar
  55. 55.
    Ward BW, Clarke TC, Freeman GJ, Schiller JS. Early release of selected estimates based on data from the 2014 National Health Interview Survey. In: U.S.Department of Health and Human Services CfDCaP, National Center for Health Statistics, ed: DHHS; 2015.Google Scholar
  56. 56.
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2016. Available at: Accessed 6 Sept 2016.

Copyright information

© Society of Surgical Oncology 2017

Authors and Affiliations

  1. 1.Breast Oncology Program, International Center for the Study of Breast Cancer SubtypesHenry Ford Health SystemDetroitUSA

Personalised recommendations